WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026

Core Viewpoint - WORK Medical Technology Group LTD has announced a one-year exclusive distribution agreement with Shanghai Benke Medical Technology Co., Ltd. for its AI-Automated Blood Cell Morphology Analyzer (CM-B600) in East China, aiming to enhance market access and commercialization of the product throughout 2026 [1][2]. Group 1: Distribution Agreement - Hunan Saitumofei has granted Shanghai Benke exclusive distribution rights for the Analyzer in East China, covering Jiangsu Province, Shanghai Municipality, and Zhejiang Province, with a minimum annual sales target of RMB 10 million (approximately US$1.4 million) [2]. - Shanghai Benke has prepaid a performance bond of RMB 1 million, which will be deducted from the final payment or refunded upon achieving the sales target [2]. Group 2: Product Details - The Analyzer received manufacturing approval as a Class II medical device in November 2025 and is certified under national and industry standards, including GB 4793.1 and YY 0648 [3]. - The Analyzer utilizes high-resolution digital imaging technology and advanced algorithms to automate sample scanning, identification, and classification, simulating manual microscopic examination [3][4]. - It can process up to 150 samples per batch, achieving an average detection time of no more than three minutes per blood smear, with a classification accuracy of no less than 90% for various white blood cell types [4]. Group 3: Technology and Features - The Analyzer employs non-deep-learning feature extraction algorithms, providing high interpretability and reducing potential clinical risks [5]. - It can identify 17 subtypes of white blood cells and offers detailed morphological analyses of red blood cells and platelets [4]. Group 4: Company Strategy - The CEO of WORK Medical expressed confidence that the agreement highlights the commercial readiness of the Analyzer and aims to leverage Shanghai Benke's established sales network to accelerate market penetration and strengthen the company's brand presence in East China [6].